欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1839/001
药品名称
Elvanse
活性成分
lisdexamfetamine dimesylate 30.0 mg
剂型
Capsule, hard
上市许可持有人
Shire Pharmaceuticals Ireland Limited Ireland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 08081/0050 - 0031
Germany (DE)
Elvanse 30 mg Hartkapseln
Denmark (DK)
Ireland (IE)
Spain (ES)
Norway (NO)
Finland (FI)
Austria (AT)
Portugal (PT)
Poland (PL)
Elvanse
Estonia (EE)
Belgium (BE)
Elvanse 30 mg gélules
Netherlands (NL)
Luxembourg (LU)
许可日期
2012/12/18
最近更新日期
2024/11/22
药物ATC编码
N06BA12 lisdexamfetamine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
con261790_pdf
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase